Idiopathic intracranial hypertension in a pediatric transgender patient

Abstract

The use of cross-sex hormone therapy (CSH) for gender affirmation may increase the risk of IIH. Awareness of this association is important as the number of younger transgender patients seeking CSH is increasing significantly.